Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (171-180 of 797) with videos related to

Pageof 80
Sort By:
The New England Journal of Medicine|July 17, 2004
C-reactive protein and coronary heart diseasePeter Libby, James T Willerson, Eugene Braunwald
Circulation|April 30, 2003
Vulnerable atherosclerotic plaque: a multifocal diseaseWard Casscells, Morteza Naghavi, James T Willerson
Texas Heart Institute Journal|January 13, 1999
Treating relentlessly progressive congestive heart failure: what next?J T Willerson, R Delgado, D Mann
Texas Heart Institute Journal|January 1, 1994
Mechanisms of restenosisW Casscells, D Engler, J T Willerson
Circulation|January 29, 2003
Coming of age of C-reactive protein: using inflammation markers in cardiologyEdward T H Yeh, James T Willerson
Journal of the American College of Cardiology|April 25, 2006
Intracoronary thermography for detection of high-risk vulnerable plaquesMohammad Madjid, James T Willerson, S Ward Casscells
Circulation|November 18, 2000
Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000)P Théroux, J T Willerson, P W Armstrong
Circulation Research|June 1, 1973
Relationship between epicardial S-T segment changes and myocardial metabolism during acute coronary insufficiencyJ Karlsson, G H Templeton, J T Willerson
Circulation|November 1, 2000
Direct proinflammatory effect of C-reactive protein on human endothelial cellsV Pasceri, J T Willerson, E T Yeh
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1971
Drug potentiation against pre-erythrocytic stages of Plasmodium falciparumK H Rieckmann, D Willerson, P E Carson
Pageof 80

Showing results (171-180 of 797) with videos related to

Sort By:
Pageof 80
The New England Journal of Medicine|July 17, 2004
C-reactive protein and coronary heart diseasePeter Libby, James T Willerson, Eugene Braunwald
Circulation|April 30, 2003
Vulnerable atherosclerotic plaque: a multifocal diseaseWard Casscells, Morteza Naghavi, James T Willerson
Texas Heart Institute Journal|January 13, 1999
Treating relentlessly progressive congestive heart failure: what next?J T Willerson, R Delgado, D Mann
Texas Heart Institute Journal|January 1, 1994
Mechanisms of restenosisW Casscells, D Engler, J T Willerson
Circulation|January 29, 2003
Coming of age of C-reactive protein: using inflammation markers in cardiologyEdward T H Yeh, James T Willerson
Journal of the American College of Cardiology|April 25, 2006
Intracoronary thermography for detection of high-risk vulnerable plaquesMohammad Madjid, James T Willerson, S Ward Casscells
Circulation|November 18, 2000
Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000)P Théroux, J T Willerson, P W Armstrong
Circulation Research|June 1, 1973
Relationship between epicardial S-T segment changes and myocardial metabolism during acute coronary insufficiencyJ Karlsson, G H Templeton, J T Willerson
Circulation|November 1, 2000
Direct proinflammatory effect of C-reactive protein on human endothelial cellsV Pasceri, J T Willerson, E T Yeh
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1971
Drug potentiation against pre-erythrocytic stages of Plasmodium falciparumK H Rieckmann, D Willerson, P E Carson
Pageof 80